SCHEMBL4610609

SCHEMBL4610609

CCOC(=O)C1(N2CCCC2=O)CCN(Cc2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 2/20 0.53
KMT2A Q03164 7/20 0.52
ALDH1A1 P00352 6/20 0.52
MEN1 O00255 5/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
L3MBTL1 Q9Y468 3/20 0.51
KDM4E B2RXH2 3/20 0.51
POLB P06746 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GAA P10253 3/20 0.49
HTT P42858 1/20 0.49
OPRM1 P35372 2/20 0.48
OPRD1 P41143 2/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.48
P4HB P07237 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158787 0.97 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C9CYP2C19LMNA
SCHEMBL11843340 0.85 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C9CYP2C19LMNA
SCHEMBL4610586 0.82 TSHR (0.49) CYP3A4CYP2D6ALDH1A1POLBOPRM1
SCHEMBL6951672 0.81 ALDH1A1 (0.48) CYP2C9CYP2C19KMT2AALDH1A1MEN1
SCHEMBL10500107 0.80 CYP3A4 (0.57) CYP3A4CYP2D6CYP2C9CYP2C19LMNA
SCHEMBL27660443 0.79 ALDH1A1 (0.38) LMNAKMT2AALDH1A1MEN1L3MBTL1
SCHEMBL2817086 0.78 CYP2D6 (0.67) CYP3A4CYP2D6CYP2C9CYP2C19LMNA
SCHEMBL26102667 0.77 LMNA (0.69) CYP3A4CYP2D6CYP2C9CYP2C19LMNA
SCHEMBL16102788 0.77 CYP3A4 (0.60) CYP3A4CYP2D6CYP2C9CYP2C19LMNA
SCHEMBL6530831 0.77 CYP2D6 (0.66) CYP3A4CYP2D6CYP2C9CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979319-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS Solvay Pharmaceuticals GmbH (DE) 2008-10-15 EP disclosed
WO-2007088181-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-08-09 WO disclosed
WO-2007088181-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-08-09 WO disclosed